BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34088020)

  • 1. Induced pluripotent stem cells derived from one 70-years-old male donor with the APOE-ε4/ε4 alleles.
    Wang J; Liu X; Du X; Ma Z; Liu B; Guo R; Feng B; Ma J; Cui H
    Stem Cell Res; 2021 May; 53():102395. PubMed ID: 34088020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-derived integration-free induced pluripotent stem cells (iPSCs) from one 53-years-old male donor with APOE-ε4/ε4 genotype.
    Ma X; Ma J; Guo R; Du J; Feng B; Liu X; Du X; Ma Z; Cui H
    Stem Cell Res; 2021 Jul; 54():102450. PubMed ID: 34218115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration-free induced pluripotent stem cell line derived from a 62-years-old male donor with APOE-epsilon4/epsilon4 alleles.
    Guo R; Liu X; Zhang J; Ma X; Gou D; Ma Z; Wang L; Ma J; Cui H
    Stem Cell Res; 2022 May; 61():102746. PubMed ID: 35305470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integration-free iPSC line, ICCSICi007-A, derived from a female Alzheimer's disease patient with the APOE-ε4/ε4 alleles.
    Díaz-Guerra E; Rodríguez-Traver E; Moreno-Jiménez EP; de Rojas I; Rodríguez C; Orera M; Hernández I; Ruiz A; Vicario C
    Stem Cell Res; 2019 Dec; 41():101588. PubMed ID: 31698192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes.
    Zhao J; Davis MD; Martens YA; Shinohara M; Graff-Radford NR; Younkin SG; Wszolek ZK; Kanekiyo T; Bu G
    Hum Mol Genet; 2017 Jul; 26(14):2690-2700. PubMed ID: 28444230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi003-A) and non-demented control (ASUi004-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant.
    Brookhouser N; Zhang P; Caselli R; Kim JJ; Brafman DA
    Stem Cell Res; 2017 Dec; 25():266-269. PubMed ID: 29246571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
    Drigalenko E; Poduslo S; Elston R
    Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
    Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
    Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E gene in physiological and pathological aging.
    Ferri E; Gussago C; Casati M; Mari D; Rossi PD; Ciccone S; Cesari M; Arosio B
    Mech Ageing Dev; 2019 Mar; 178():41-45. PubMed ID: 30658061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer's disease pathology.
    Chemparathy A; Le Guen Y; Chen S; Lee EG; Leong L; Gorzynski JE; Jensen TD; Ferrasse A; Xu G; Xiang H; Belloy ME; Kasireddy N; Peña-Tauber A; Williams K; Stewart I; Talozzi L; Wingo TS; Lah JJ; Jayadev S; Hales CM; Peskind E; Child DD; Roeber S; Keene CD; Cong L; Ashley EA; Yu CE; Greicius MD
    Neuron; 2024 Apr; 112(7):1110-1116.e5. PubMed ID: 38301647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.
    Hirono N; Hashimoto M; Yasuda M; Ishii K; Sakamoto S; Kazui H; Mori E
    Neurology; 2002 Mar; 58(5):743-50. PubMed ID: 11889238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
    Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human induced pluripotent stem cell (iPSC) line (HEBHMUi014-A) derived from a patient with Alzheimer's disease.
    Zhang M; Yu M; Guo R; Zhang Y; Zhang X; Sun J; Zhang J; Wang X; Ma J
    Stem Cell Res; 2023 Jun; 69():103116. PubMed ID: 37178573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphisms Ser447Ter of lipoprotein-lipase gene, Cys112Arg and Arg158Cys of apolipoprotein E gene in patients with obesity].
    Kirillova OO; Vorozhko IV; Gapparova KM; Chekhonina IuG; Sentsova TB; Tutel'ian VA
    Vopr Pitan; 2013; 82(4):4-9. PubMed ID: 24340925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization on the role of APOE polymorphism in human hippocampal neurogenesis.
    Lee H; Price J; Srivastava DP; Thuret S
    Hippocampus; 2023 Apr; 33(4):322-346. PubMed ID: 36709412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.